Rebecca L. Porter, MD, PhD

Video

Rebecca Porter, MD, PhD Discusses Endometrial Cancer Research at AACR24

Dana-Farber's Rebecca Porter, MD, PhD, says antibody-drug conjugate combined with immunotherapy had impressive overall response rate in 16 patients with a rare subtype, but more research is needed.